|
66
|
230
|
5lf6A |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
63
|
200
|
5lf3K |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
62
|
244
|
5lf6G |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
54
|
204
|
5lf7I |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
76
|
248
|
5leyB |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
200
|
5lf1K |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
57
|
202
|
5lf4N |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
64
|
237
|
5lf1C |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
64
|
234
|
5lf4E |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
68
|
213
|
5lf3L |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
55
|
202
|
5lf3N |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
54
|
196
|
5lf7J |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
62
|
237
|
5lezC |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
75
|
248
|
5lf4B |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
62
|
220
|
5lf3H |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
64
|
230
|
5lf1A |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
55
|
204
|
5lf1I |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
66
|
230
|
5lezA |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
66
|
216
|
5lf0M |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
68
|
213
|
5lf1L |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
66
|
237
|
5lf4C |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
66
|
237
|
5lf3C |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
62
|
233
|
5lf3D |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
67
|
230
|
5lf4A |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
64
|
244
|
5lezG |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
216
|
5lf7M |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
66
|
239
|
5lf7F |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
73
|
248
|
5lf7B |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
74
|
248
|
5lf1B |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
62
|
195
|
5l52J |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
58
|
222
|
5l52L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
72
|
212
|
5l52K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
70
|
244
|
5l5tB |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
62
|
231
|
5l5qE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
66
|
250
|
5l5pA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
211
|
5l5rK |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
65
|
250
|
5l5fA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
222
|
5l5iL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
65
|
211
|
5l5sK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
62
|
231
|
5l54E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
70
|
243
|
5l55F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
62
|
211
|
5l5eK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
63
|
211
|
5l5bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
61
|
211
|
5l5dK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
71
|
243
|
5l52F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
71
|
243
|
5l5sF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
65
|
231
|
5l5fE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
59
|
226
|
5l5sH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
242
|
5l5qD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
69
|
244
|
5l5qB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
